SELLAS Life Sciences SLS
NASDAQ SLS
$11.74 +0.41 (+3.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Amortizatization of Intangibles (2017)

Updated

SELLAS Life Sciences (SLS) reported Amortizatization of Intangibles of $1,000 for Q4 2017, down 96.3% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Amortizatization of Intangibles (2017) Analysis & Trends

For FY2017, SELLAS Life Sciences posted Amortizatization of Intangibles of $258,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 SELLAS Life Sciences 2.37 Bn 2.37 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1,000.00
Sep 30, 2017 27,000.00
API Access

SELLAS Life Sciences Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=SLS&period=max&api_key=YOUR_API_KEY